Avisa Diagnostics, Inc. is a clinical stage medical device company. It engages in the development of Avisa Breath Test, which is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load without the need to collect and culture sputum samples. The company was founded on February 7, 1984 and is headquartered in Santa Fe, NM.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company